An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension.

Trial Profile

An Open-label Study of the Single-dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients With Hypertension.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Daiichi Sankyo Europe
  • Most Recent Events

    • 09 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 11 Mar 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 13 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top